Cowen and Company’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Cowen and Company’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-69,160	Closed	-$2.61M	–	709
2023 Q3	$2.61M	Sell	69,160 -1,446	-2%	-$54.3K	0.18%	96
2023 Q2	$2.68M	Hold	70,606	–	–	0.22%	82
2023 Q1	$1.72M	Hold	70,606	–	–	0.2%	68
2022 Q4	$2.05M	Buy	+70,606	New	+$2.09M	0.21%	61

Other funds holding TARO

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cowen and Company's TARO Position: Q4 2023 in Review

Cowen and Company sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2023, closing a stake of 69,160 shares — an estimated $2.61M sold.

Cowen and Company first reported a position in TARO in Q4 2022 and held it in 4 quarters. The position peaked at $2.68M in Q2 2023. 90 funds tracked by Wall St. Rank hold TARO as of Q4 2023.

Cowen and Company reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2023 after selling out during the quarter.
Cowen and Company sold 69,160 Taro Pharmaceutical Industries Ltd. shares in Q4 2023, an estimated $2.61M.
Cowen and Company first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2022 and held it in 4 quarters.
Cowen and Company's Taro Pharmaceutical Industries Ltd. position peaked at $2.68M in Q2 2023.
90 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.